A quantitative study of the pathological changes in the cerebellum in 15 cases of variant Creutzfeldt-Jakob disease (vCJD).

PubWeight™: 0.90‹?›

🔗 View Article (PMID 19187059)

Published in Neuropathol Appl Neurobiol on February 01, 2009

Authors

R A Armstrong1, J W Ironside, P L Lantos, N J Cairns

Author Affiliations

1: Vision Sciences, Aston University, Birmingham, UK. r.a.armstrong@aston.ac.uk

Articles by these authors

A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15

Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73

Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24

Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron (1992) 4.22

Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci (1989) 4.01

Prion dementia without characteristic pathology. Lancet (1990) 3.66

Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol (2006) 3.29

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett (1998) 3.26

Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature (1996) 3.09

Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet (1998) 3.08

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02

The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet (2000) 2.92

Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68

Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet (2000) 2.59

Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A (2000) 2.50

Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46

Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol (2000) 2.42

Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10

Deaths from variant Creutzfeldt-Jakob disease. Lancet (1999) 2.04

Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders. Haemophilia (2010) 2.03

High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol (1997) 2.00

Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93

Diagnosing dementia: do we get it right? BMJ (1988) 1.85

Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet (2001) 1.84

Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet (1999) 1.79

Brain capillary endothelial cells in vitro lack surface IgG Fc receptors. Neurosci Lett (1986) 1.74

Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol (1996) 1.66

Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry (1994) 1.60

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology (2010) 1.58

The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain (1999) 1.56

Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol (2007) 1.51

Gliosarcoma with areas of primitive neuroepithelial differentiation and extracranial metastasis. Clin Neuropathol (2001) 1.49

ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol (2008) 1.49

Diagnostic criteria for corticobasal degeneration. J Neurol Neurosurg Psychiatry (2000) 1.48

Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia (2010) 1.45

Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain (2000) 1.43

Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest (1999) 1.42

The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain (1994) 1.41

Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. J Neurol Neurosurg Psychiatry (1989) 1.41

In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol (2007) 1.41

Progressive ataxia, focal seizures, and malabsorption syndrome in a 41 year old woman. J Neurol Neurosurg Psychiatry (1996) 1.39

The fine structure of periventricular pleomorphic gliomas induced transplacentally by N-ethyl-N-nitrosourea in BD-IX rats. With a note on their origin. J Neurol Sci (1972) 1.38

Creutzfeldt-Jakob disease: implications for gastroenterology. Gut (2002) 1.38

Brain tissue banks in psychiatric and neurological research. J Clin Pathol (1996) 1.38

An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem (1997) 1.36

Characterization of the human cell line TE671. Carcinogenesis (1989) 1.34

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol (Paris) (2013) 1.33

Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). Ann Neurol (1996) 1.32

The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol (1999) 1.31

Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.30

Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's disease. Neurosci Lett (1995) 1.28

Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol (2004) 1.26

Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25

The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol (2005) 1.22

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet (1999) 1.22

Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain (1997) 1.22

Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci (1992) 1.21

Studies of the morphology and tumorigenicity of experimental brain tumours in tissue culture. Br J Exp Pathol (1976) 1.20

Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport (2001) 1.19

Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis (1993) 1.18

Registration quality and descriptive epidemiology of childhood brain tumours in Scotland 1975-90. Br J Cancer (1994) 1.18

Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-gamma, tumour necrosis factor and interleukin-1. Immunology (1988) 1.17

Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol (1998) 1.17

The origin of experimental brain tumours: a sequential study. Experientia (1976) 1.17

Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride. J Pharm Pharmacol (1988) 1.16

A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. Cancer (2000) 1.16

The development of experimental brain tumours. A sequential light and electron microscope study of the subependymal plate. I. Early lesions (abnormal cell clusters). Acta Neuropathol (1979) 1.14

Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet (1994) 1.14

Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14

Is the neuropathology of new variant Creutzfeldt-Jakob disease and kuru similar? Lancet (1997) 1.14

Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology (2000) 1.13

Prion protein immunocytochemistry--UK five centre consensus report. Neuropathol Appl Neurobiol (1997) 1.13

Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol (1996) 1.12

Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol (1997) 1.11

Microglia and the pathogenesis of spongiform encephalopathies. Brain Res Brain Res Rev (2001) 1.11

Distribution and fine structural analysis of undifferentiated cells in the primate subependymal layer. J Anat (1991) 1.10

Core features of frontotemporal dementia recapitulated in progranulin knockout mice. Neurobiol Dis (2011) 1.10

A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol (2009) 1.10

Pick's disease is associated with mutations in the tau gene. Ann Neurol (2000) 1.10

Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09

Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol (1999) 1.09

The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis. J Neurol Sci (1981) 1.09

Bovine spongiform encephalopathy and risk to health. BMJ (1992) 1.08

Neuropathology of spongiform encephalopathies in humans. Br Med Bull (1993) 1.08

DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinicopathological correlates. J Neurosurg (1987) 1.07

Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol (1999) 1.07

Neuropathologic variation in frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology (2002) 1.07